This observation supports the prevailing understanding of the molecular pathogenesis of cSCC according to which inactivation of TP53 and activation of EGFR/MAPK-signaling pathways are frequent events in cSCC that lead to activation of RAS-RAF-MEK signaling pathway5. The gene discussed is TP53; the disease is skin squamous cell carcinoma.